LLY
745.48
-1.34%↓
JNJ
153.61
+0.7%↑
UNH
321.58
+1.9%↑
ABBV
184.82
-0.47%↓
NVO
68.12
+1.76%↑
LLY
745.48
-1.34%↓
JNJ
153.61
+0.7%↑
UNH
321.58
+1.9%↑
ABBV
184.82
-0.47%↓
NVO
68.12
+1.76%↑
LLY
745.48
-1.34%↓
JNJ
153.61
+0.7%↑
UNH
321.58
+1.9%↑
ABBV
184.82
-0.47%↓
NVO
68.12
+1.76%↑
LLY
745.48
-1.34%↓
JNJ
153.61
+0.7%↑
UNH
321.58
+1.9%↑
ABBV
184.82
-0.47%↓
NVO
68.12
+1.76%↑
LLY
745.48
-1.34%↓
JNJ
153.61
+0.7%↑
UNH
321.58
+1.9%↑
ABBV
184.82
-0.47%↓
NVO
68.12
+1.76%↑
24h
Praegune
Min
1.69
Max
1.79
Soovitused | Osta |
---|---|
12 kuu keskmine prognoos | +468.18% upside |
Järgmine tulemuste avaldamine | 11. aug 2025 |
---|
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
10. märts 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Loe
10. märts 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Loe
10. märts 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Loe
10. märts 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Loe
10. märts 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Loe
10. märts 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Loe
10. märts 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Loe
Hinnamuutus
By TipRanks
12 kuu keskmine prognoos
Keskmine 10 USD 468.18%
Kõrge 16 USD
Madal 4 USD
Põhineb 2 Wall Streeti analüütiku instrumendi Fortress Biotech Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
By TipRanks
Osta
2 ratings
2
Osta
0
Hoia
0
Müü
Põhineb 2 analüütiku instrumendi Fortress Biotech Inc aktsia reitingul - viimase 3 kuu andmed.
$